Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction
- 8 October 2009
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 29 (12), 1118-1122
- https://doi.org/10.1002/pd.2372
Abstract
Objective: To determine if maternal plasma ffDNA is increased early in pregnancies which subsequently develop preeclampsia (PE) and intrauterine growth restriction (IUGR).Methods: Blood was obtained at 11–14 weeks and plasma stored. Among those who delivered a male infant and had a birth weight under the tenth centile and/or PE, we divided them into those who delivered before 35 weeks (9) and those who delivered after this gestation (15). A third group with uncomplicated pregnancies was used as controls (24). Real time‐polymerase chain reaction (RT‐PCR) was carried out to detect the multi‐copy Y chromosome associated DSY14 gene.Results: There were no differences between the ffDNA levels in the group delivered after 35 weeks and the control group (2.23ge/mL–1.61ge/mL p = 0.39). However, the levels of ffDNA at 11–14 weeks were statistically, significantly higher in patients that delivered before 35 weeks (4.34ge/mL–1.61ge/mL p = 0.0018). A logistic regression analysis shows that for every unit (1ge/mL) in which ffDNA increases, the likelihood of having PE or a fetus growing under the tenth centile delivered before 35 weeks increases by 1.67 times (CI 1.13–2.47).Conclusion: The concentration of ffDNA is significantly higher even during early pregnancy, in patients who subsequently develop PE and/or IUGR and are delivered before 35 weeks. Copyright © 2009 John Wiley & Sons, Ltd.Funding Information
- FONDECYT (1 080 373, 1 050 482)
This publication has 26 references indexed in Scilit:
- Trophoblastic Oxidative Stress and the Release of Cell-Free Feto-Placental DNAThe American Journal of Pathology, 2006
- Inflammation and pre-eclampsiaSeminars in Fetal and Neonatal Medicine, 2006
- Fetal Cells and Cell Free Fetal Nucleic Acids in Maternal Blood: New Tools to Study Abnormal Placentation?Placenta, 2005
- Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- Fetal Cell‐Free Nucleic Acids in the Maternal Circulation: New Clinical ApplicationsAnnals of the New York Academy of Sciences, 2004
- Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP)Hypertension in Pregnancy, 2001
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisAmerican Journal of Human Genetics, 1998
- Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implicationsAmerican Journal of Obstetrics and Gynecology, 1996
- Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnanciesVirchows Archiv B Cell Pathology Including Molecular Pathology, 1991